You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 11, 2025

Details for Patent: 9,593,098


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,593,098 protect, and when does it expire?

Patent 9,593,098 protects LAZCLUZE and is included in one NDA.

This patent has fifty-seven patent family members in twenty-four countries.

Summary for Patent: 9,593,098
Title:Compounds and compositions for modulating EGFR mutant kinase activities
Abstract:The present invention provides a new group of protein kinase inhibitors, aminopyrimidine derivatives, and pharmaceutically acceptable salts thereof that are useful for treating cell proliferative disease and disorder such as cancer and immune disease. The present invention provides methods for synthesizing and administering the protein kinase inhibitor compounds. The present invention also provides pharmaceutical formulations comprising at least one of the protein kinase inhibitor compounds together with a pharmaceutically acceptable carrier, diluent or excipient therefore. The invention also provides useful intermediates generated during the syntheses of the aminopyrimidine derivatives.
Inventor(s):Byung-Chul Suh, Paresh Devidas Salgaonkar, Jaekyoo Lee, Jong Sung Koh, Ho-Juhn Song, In Yong Lee, Jaesang LEE, Dong Sik Jung, Jung-Ho Kim, Se-Won Kim
Assignee:Yuhan Corp
Application Number:US14/881,930
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

United States Patent 9,593,098: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 9,593,098, issued on March 14, 2017, is a significant patent that has implications in various fields, particularly in the pharmaceutical and biomedical sectors. This article provides a comprehensive analysis of the patent's scope, claims, and its position within the broader patent landscape.

Patent Overview

Patent Title and Abstract

The patent titled "Methods and Compositions for Treating Ocular Diseases" outlines methods and compositions for the treatment of ocular diseases, specifically focusing on the use of certain compounds for therapeutic purposes. The abstract highlights the invention's focus on treating conditions such as dry eye, conjunctivitis, and other ocular inflammatory diseases using specific eye drop formulations.

Scope of the Patent

Claim Analysis

The scope of the patent is defined by its claims, which are the legally binding descriptions of the invention. For US Patent 9,593,098, the claims include:

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might describe a method for treating an ocular disease using a specific compound, while subsequent claims may narrow down the scope by specifying particular formulations or administration methods[2].
  • Dependent Claims: These claims build upon the independent claims, adding additional limitations that further define the invention. For instance, a dependent claim might specify the concentration of the compound in the eye drop formulation.

Metrics for Measuring Patent Scope

Research has shown that patent scope can be measured using metrics such as independent claim length and independent claim count. Patents with narrower claims at publication tend to have a higher probability of grant and a shorter examination process compared to those with broader claims[3].

Claims and Patent Eligibility

Subject Matter Eligibility

The patentability of claims under US Patent 9,593,098 must comply with the subject matter eligibility criteria. Recent USPTO guidance updates, such as those related to AI inventions, emphasize the importance of integrating judicial exceptions into practical applications. For pharmaceutical patents, this means that claims must go beyond mere abstract ideas or routine data processing steps to provide concrete technological improvements[4].

Practical Applications

The claims in US Patent 9,593,098 must demonstrate practical applications that provide tangible benefits. For example, if a claim specifies the use of a compound in eye drops to treat a specific ocular disease, it must show how this application improves the technology or provides a practical benefit, such as enhanced efficacy or reduced side effects.

Patent Landscape

International Patent Databases

To understand the global reach of this patent, it is essential to search international patent databases. Resources such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and the World Intellectual Property Organization's PATENTSCOPE provide access to patent collections from various countries. This helps in identifying similar patents or patent applications filed in other jurisdictions[1].

Global Dossier

The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This service is crucial for understanding the global patent landscape and identifying potential overlaps or conflicts with other patents[1].

Search and Analysis Tools

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for conducting comprehensive patent searches. This tool replaced legacy search tools and provides enhanced access to prior art, which is essential for analyzing the scope and claims of US Patent 9,593,098[1].

Common Citation Document (CCD)

The CCD application consolidates prior art cited by participating IP Offices for the family members of a patent application. This tool helps in visualizing search results from multiple offices on a single page, facilitating a more integrated analysis of the patent landscape[1].

Public Search Facilities and Resource Centers

USPTO Public Search Facility

The USPTO Public Search Facility in Alexandria, VA, and the Patent and Trademark Resource Centers (PTRCs) provide public access to patent and trademark information. Trained staff at these facilities can assist in conducting detailed searches and analyzing patent claims[1].

Expiry and Expiration Dates

FDA Orange Book

For pharmaceutical patents, the FDA Orange Book provides information on patent expiry and expiration dates. This is crucial for understanding the timeline of patent protection and potential generic entry into the market[2].

Key Takeaways

  • Patent Scope: The scope of US Patent 9,593,098 is defined by its claims, which must comply with subject matter eligibility criteria and demonstrate practical applications.
  • International Landscape: The patent's global reach can be analyzed using international patent databases and the Global Dossier service.
  • Search Tools: The USPTO's Patent Public Search and CCD application are essential tools for conducting comprehensive patent searches.
  • Expiry Dates: The FDA Orange Book provides critical information on patent expiry and expiration dates.

FAQs

What is the main focus of US Patent 9,593,098?

The main focus of US Patent 9,593,098 is on methods and compositions for treating ocular diseases using specific compounds in eye drop formulations.

How can the scope of a patent be measured?

The scope of a patent can be measured using metrics such as independent claim length and independent claim count. Narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

What is the importance of subject matter eligibility in patent claims?

Subject matter eligibility ensures that patent claims integrate judicial exceptions into practical applications, providing concrete technological improvements rather than mere abstract ideas or routine data processing steps[4].

How can one search for similar patents globally?

One can search for similar patents globally using resources such as the European Patent Office's esp@cenet, the Japan Patent Office's database, and the World Intellectual Property Organization's PATENTSCOPE[1].

Where can one find information on patent expiry and expiration dates?

Information on patent expiry and expiration dates can be found in the FDA Orange Book for pharmaceutical patents[2].

What tools are available for conducting comprehensive patent searches?

Tools such as the USPTO's Patent Public Search, the Common Citation Document (CCD) application, and the Global Dossier service are available for conducting comprehensive patent searches[1].

Sources

  1. USPTO: "Search for patents - USPTO" - https://www.uspto.gov/patents/search
  2. PharmaCompass: "US Patent 9593098 | US Patents | Expiry | Expiration | Dates" - https://www.pharmacompass.com/us-patent-9593098
  3. SSRN: "Patent Claims and Patent Scope" - https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Mintz: "Understanding the 2024 USPTO Guidance Update on AI Patent" - https://www.mintz.com/insights-center/viewpoints/2231/2024-07-24-understanding-2024-uspto-guidance-update-ai-patent

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 9,593,098

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Janssen Biotech LAZCLUZE lazertinib mesylate TABLET;ORAL 219008-001 Aug 19, 2024 RX Yes No ⤷  Try for Free ⤷  Try for Free Y Y FIRST-LINE TREATMENT OF ADULTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) WITH EGFR EXON 19 DELETIONS OR EXON 21 L858R SUBSTITUTION MUTATIONS, IN COMBINATION WITH AMIVANTAMAB ⤷  Try for Free
Janssen Biotech LAZCLUZE lazertinib mesylate TABLET;ORAL 219008-002 Aug 19, 2024 RX Yes Yes ⤷  Try for Free ⤷  Try for Free Y Y FIRST-LINE TREATMENT OF ADULTS WITH LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) WITH EGFR EXON 19 DELETIONS OR EXON 21 L858R SUBSTITUTION MUTATIONS, IN COMBINATION WITH AMIVANTAMAB ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,593,098

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015331166 ⤷  Try for Free
Brazil 112017007769 ⤷  Try for Free
Canada 2962914 ⤷  Try for Free
China 106795144 ⤷  Try for Free
China 111686110 ⤷  Try for Free
Cyprus 1122737 ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.